Abstract
Background/purpose Adrenaline infused into the posterior segment of the eye during vitreoretinal surgery may be absorbed and give rise to unwanted cardiovascular effects. We sought to establish whether significant amounts of adrenaline are systemically absorbed.
Methods This study was prospective and double-masked, with patients randomised into two groups. The first group received a posterior segment infusion containing Hartmann's solution alone (Hs group) and the second group received a posterior segment infusion of Hartmann's solution containing 0.5 ml of 1:1000 (0.5 mg) adrenaline per 500 ml (Hs+Ad group). Pre-medication and anaesthetic techniques were standardised for all patients. Venous blood samples were collected prior to induction, 5 min following intubation and 5,10, 15 and 30 min following the commencement of the infusion. Samples were analysed for adrenaline levels using high-performance liquid chromatography.
Results Ten patients were studied: 4 in the Hs group and 6 in the Hs+Ad group. The mean dose of adrenaline administered in the Hs+Ad group was 655.08 nmol (0.12 mg). The median serum adrenaline level following infusion for the Hs+Ad group was 0.15 nmol/l (LQ = 0.100, UQ = 0.360) and the median serum adrenaline level for the Hs group was 0.10 nmol/l (LQ = 0.100, UQ = 0.350). There was no overall statistical difference in the levels of serum adrenaline between the two groups, and furthermore adrenaline levels remained within physiological parameters for both groups.
Conclusion There does not appear to be significant adrenaline absorption from posterior segment infusion. Continued caution should be exercised, however, as idiosyncratic reactions may still occur.
Similar content being viewed by others
Article PDF
References
Smith RB, Douglas J, Petruscak J, Breslin P . Safety of intraocular adrenaline with halothane anaesthesia. Br J Anaesth 1972;44:1314–6.
Ballin N, Becker B, Goldman ML . Systemic effects of epinephrine applied topically to the eye. Invest Ophthalmol 1966;5:125–9.
Lansche RK . Systemic reactions to topical epinephrine and phenylephrine. Am J Ophthalmol 1966;62:95–8.
Kerr CR, Hass I, Drance SM . Cardiovascular side effects of epinephrine and dipivalylepinephrine applied topically to the eye in patients with glaucoma. Br J Ophthalmol 1982;66:109–14.
Anderson JA . Systemic absorption of topically applied epinephrine and dipivefrine. Arch Ophthalmol 1980;98:350–1.
Dahlof C, Meilstrand T, Svendmyr N . Systemic absorption of adrenaline after aerosol, eye-drop and subcutaneous administration to healthy volunteers. Allergy 1987;42:215–21.
Donlon JV, Moss J . Plasma catecholamine levels during local anaesthesia for cataract operations. Anaesthesiology 1979;51:471–3.
Low JM, Harvey JT, Cooper GM, Prenderville WJ . Plasma concentrations of catecholamines following adrenaline infiltration during gynaecological surgery. Br J Anaesth 1984;56:849–52.
Webster NR, Hinton W . Topical adrenaline [letter]. Anaesthesia 1986;41:435.
Author information
Authors and Affiliations
Additional information
Sponsored by the Moorfields Locally Organised Research Fund
Rights and permissions
About this article
Cite this article
Heyworth, P., Bourke, R., Moore, C. et al. The systemic absorption of adrenaline from posterior segment infusion during vitreoretinal surgery. Eye 12, 949–952 (1998). https://doi.org/10.1038/eye.1998.246
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.246